Biotech · Private company
Blue Note Therapeutics
Track this companyFree. Adds Blue Note Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Attune™Anatomic Stage I Breast Cancer AJCC v8ClinicalTrials.gov · fetched Nov 12, 2026
- BNT001CancerClinicalTrials.gov · fetched Nov 12, 2026
- BNT103Breast Cancer FemaleClinicalTrials.gov · fetched Nov 12, 2026
- Cerena™Anatomic Stage I Breast Cancer AJCC v8ClinicalTrials.gov · fetched Nov 12, 2026
- Device: Attune™CancerClinicalTrials.gov · fetched Nov 12, 2026
- Device: Cerena™CancerClinicalTrials.gov · fetched Nov 12, 2026
- Long-term follow-up of attune™CancerClinicalTrials.gov · fetched Nov 12, 2026
- Long-term follow-up of cerena™CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Long-term Follow-up of RESTORE StudyUNKNOWN · started Oct 31, 2022ClinicalTrials.gov NCT05647785 · fetched Nov 12, 2026
- Psychological Mobile App for Patients With AMLNA · TERMINATED · started Oct 15, 2022ClinicalTrials.gov NCT05501171 · fetched Nov 12, 2026
- Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With CancerNA · UNKNOWN · started Mar 10, 2022ClinicalTrials.gov NCT05227898 · fetched Nov 12, 2026
- BNT001 Digital Therapeutic Feasibility Pilot StudyNA · TERMINATED · started Oct 8, 2021ClinicalTrials.gov NCT04857008 · fetched Nov 12, 2026
- Blue Note Therapeutics Product BNT 103 Usability and User EngagementNA · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT05032404 · fetched Nov 12, 2026
- Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology TreatmentNA · TERMINATED · started May 15, 2021ClinicalTrials.gov NCT04862195 · fetched Nov 12, 2026
- Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNA · TERMINATED · started Apr 8, 2021ClinicalTrials.gov NCT04705025 · fetched Nov 12, 2026